CHAMBERS MICHAEL ANDREW purchased 19.5% of their position (34.87K shares) of SAREPTA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $3.70M — a significant purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 8/11/2023ACC: 0001209191-23-045366
Director
Since Jun 2022
+34.87K
Net shares
Net buyer
$3.70M
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
34.87K acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+2.21K
Price / share
$104.67
Trade value
$230.90K
% of position
1.2%
8/10/2023
178.46K→180.67K
Common Stock
Indirect
Shares
+1.09K
Price / share
$105.90
Trade value
$115.54K
% of position
0.6%
8/10/2023
180.67K→181.76K
Common Stock
Indirect
Shares
+31.57K
Price / share
$106.26
Trade value
$3.35M
% of position
17.4%
8/10/2023
181.76K→213.33K
Total
Net shares
+34.87K
Net value
$3.70M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/10/2023 | P · Purchase | +2.21K | $104.67 | $230.90K | 1.2% | 178.46K | 180.67K |
| Common Stock Indirect | 8/10/2023 | P · Purchase | +1.09K | $105.90 | $115.54K | 0.6% | 180.67K | 181.76K |
| Common Stock Indirect | 8/10/2023 | P · Purchase | +31.57K | $106.26 | $3.35M | 17.4% | 181.76K | 213.33K |
| Total | +34.87K | $3.70M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned6.43K
Total
6.43K direct6.43K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.43K | Direct |
| Total | 6.43K | 6.43K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported